Developing a <i>Chromochloris zofingiensis</i> Mutant for Enhanced Production of Lutein under CO<sub>2</sub> Aeration

Yuanyuan Ren,Jinquan Deng,Yan Lin,Junchao Huang,Feng Chen
DOI: https://doi.org/10.3390/md20030194
2022-01-01
Marine Drugs
Abstract:Microalgae are competitive and commercial sources for health-benefit carotenoids. In this study, a Chromochloris zofingiensis mutant (Cz-pkg), which does not shut off its photosystem and stays green upon glucose treatment, was generated and characterized. Cz-pkg was developed by treating the algal cells with a chemical mutagen as N-methyl-N'-nitro-N-nitrosoguanidine and followed by a color-based colony screening approach. Cz-pkg was found to contain a dysfunctional cGMP-dependent protein kinase (PKG). By cultivated with CO2 aeration under mixotrophy, the mutant accumulated lutein up to 31.93 +/- 1.91 mg L-1 with a productivity of 10.57 +/- 0.73 mg L-1 day(-1), which were about 2.5- and 8.5-fold of its mother strain. Besides, the lutein content of Cz-pkg could reach 7.73 +/- 0.52 mg g(-1) of dry weight, which is much higher than that of marigold flower, the most common commercial source of lutein. Transcriptomic analysis revealed that in the mutant Cz-pkg, most of the genes involved in the biosynthesis of lutein and chlorophylls were not down-regulated upon glucose addition, suggesting that PKG may regulate the metabolisms of photosynthetic pigments. This study demonstrated that Cz-pkg could serve as a promising strain for both lutein production and glucose sensing study.
What problem does this paper attempt to address?